98%
921
2 minutes
20
Purpose: Colposcopy-directed biopsy is a cornerstone method for diagnosing cervical intraepithelial neoplasia. The aim of this study was to evaluate the accuracy of colposcopy-directed biopsy in comparison with definitive surgery.
Methods: The accuracy of colposcopy-directed biopsy was compared with the final histology in relation to different types of transformation zone (TZ), the patient's age, and the examiner's level of training.
Results: The overall accuracy of biopsy in comparison with definitive surgery was 71.9% for all entities-benign lesions, low-grade squamous intraepithelial lesions, high-grade squamous intraepithelial lesions (HSILs), and cervical carcinoma-with an underdiagnosis rate of 11.8% and an overdiagnosis rate of 16.5%. The accuracy for detecting HSIL was 88% (401/455), with an underdiagnosis rate of 10.5% and overdiagnosis rate of 1.3%. The accuracy rates for detecting HSIL in women with TZ 1, TZ 2, or TZ 3 were 92.2, 90.5, and 76.5%, respectively. The accuracy rates for detecting HSIL in the different age groups were 93.1% (age 0-34), 83.6% (age 34-55), and 80% (age 55 or older).
Conclusions: A combination of the colposcopic findings, cytology, human papillomavirus testing, and colposcopy-directed biopsy is necessary for the correct diagnosis of HSIL. The accuracy rate depends on the TZ and the patient's age. The examiner's level of training does not have any substantial influence on the accuracy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00404-018-4953-8 | DOI Listing |
J Clin Med
July 2025
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland.
: Vaginal intraepithelial neoplasia (VaIN) is a rare but potentially precancerous condition strongly associated with human papillomavirus (HPV) infection. Despite increased detection rates due to HPV screening and colposcopy, diagnosis and management remain challenging. This study aimed to evaluate the epidemiological characteristics, risk factors, and outcomes of VaIN in patients referred to a tertiary academic center.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
August 2025
Dow University of Health Sciences, Karachi, Pakistan.
Objective: To evaluate the effectiveness of lidocaine spray in reducing pain during colposcopy-directed cervical biopsy (CDB) by reviewing evidence from published randomized controlled trials (RCTs).
Methods: A search was conducted on PubMed and Google Scholar databases for RCTs investigating the use of lidocaine spray to manage pain during CDB. Pain scores during biopsy were the primary outcome, with secondary outcomes including pain during speculum insertion, endocervical curettage, and post-procedure.
Int J Mol Sci
May 2025
Department of Obstetrics and Gynecology, Sørlandet Hospital Kristiansand, 4604 Kristiansand, Norway.
Cervical intraepithelial neoplasia (CIN) is caused by human papillomavirus (HPV); however, factors such as HPV genotype and individual immune response may also contribute to its development. The loop electrosurgical excision procedure (LEEP) is a treatment for high-grade cervical intraepithelial neoplasia (CIN), as approximately 30% of these cases may progress to cancer. However, 20-40% of cases will regress spontaneously.
View Article and Find Full Text PDFBMC Infect Dis
May 2025
Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China, 999780.
Background: The synchronous occurrence of adenocarcinoma and squamous cell carcinoma in distinct cervical regions is exceptionally rare. This report highlights a case of HPV-associated adenocarcinoma and squamous cell carcinoma at distinct sites in a patient with primary stage IA1 cervical cancer.
Case Presentation: A 54-year-old female tested HPV type 18 positive in a routine physical exam.
Diagn Cytopathol
June 2025
Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Background: Screening for cervical cancer may include cervical cytology and/or high-risk human papillomavirus testing (HPV). The FDA (Food and Drug Administration)-approved CINtec PLUS dual stain (DS) for p16 and Ki-67 can provide helpful information for challenging follow-up care.
Methods: We retrospectively analyzed 272 cases with negative intraepithelial malignancy (NILM) Papanicolaou (Pap) tests and positive HPV test results.